Community Trust & Investment Co. held its stake in shares of Stryker Corporation (NYSE:SYK) during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 12,225 shares of the medical technology company’s stock at the end of the first quarter. Community Trust & Investment Co.’s holdings in Stryker Corporation were worth $1,609,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of the company. Bollard Group LLC boosted its stake in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock valued at $109,000 after buying an additional 3 shares during the last quarter. Baystate Wealth Management LLC boosted its stake in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock valued at $139,000 after buying an additional 22 shares during the last quarter. Guardian Life Insurance Co. of America boosted its stake in shares of Stryker Corporation by 0.8% in the first quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after buying an additional 9 shares during the last quarter. Assetmark Inc. boosted its stake in shares of Stryker Corporation by 0.3% in the first quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock valued at $168,000 after buying an additional 4 shares during the last quarter. Finally, Daiwa SB Investments Ltd. purchased a new stake in shares of Stryker Corporation during the first quarter valued at $170,000. 73.99% of the stock is currently owned by institutional investors.

Stryker Corporation (NYSE:SYK) traded up 0.41% during midday trading on Friday, hitting $144.50. The company had a trading volume of 262,257 shares. Stryker Corporation has a 52 week low of $106.48 and a 52 week high of $148.84. The stock has a 50 day moving average price of $143.63 and a 200-day moving average price of $135.35. The stock has a market capitalization of $54.05 billion, a PE ratio of 32.25 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.51 by $0.02. The business had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.39 EPS. On average, equities analysts predict that Stryker Corporation will post $6.50 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be paid a dividend of $0.425 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.70 annualized dividend and a yield of 1.18%. Stryker Corporation’s payout ratio is presently 37.95%.

COPYRIGHT VIOLATION NOTICE: “Community Trust & Investment Co. Has $1,609,000 Position in Stryker Corporation (SYK)” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/08/11/community-trust-investment-co-has-1609000-position-in-stryker-corporation-syk.html.

Several equities research analysts recently weighed in on the company. Stifel Nicolaus upped their price target on Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. BidaskClub cut Stryker Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Goldman Sachs Group, Inc. (The) assumed coverage on Stryker Corporation in a research note on Tuesday, May 16th. They issued a “neutral” rating and a $129.00 price target on the stock. Cowen and Company set a $150.00 price target on Stryker Corporation and gave the stock an “outperform” rating in a research note on Wednesday, April 26th. Finally, Barclays PLC reaffirmed a “sell” rating and issued a $133.00 price target on shares of Stryker Corporation in a research note on Thursday, April 27th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $144.03.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider David Floyd sold 19,305 shares of the business’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total value of $2,790,730.80. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,810 shares of company stock worth $4,754,958. Company insiders own 7.40% of the company’s stock.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with MarketBeat.com's FREE daily email newsletter.